Arq Inc

ARQ remains in a Stage 2 advance with medium-term bullish structure but recent weakness into flat short-term EMAs and high Stage Transition Risk suggests deferred entries. A speculative bias favors waiting for a pullback into rising EMAs or the prior consolidation range for evidence of absorption before commitment.

• ↑2025 revenue $120M (+10% YoY), 2026 guidance $120–125M on strong PAC demand
• ↑Adjusted EBITDA guidance of $17–20M for 2026 reflects operational efficiency gains
• ↓GAC production paused due to design flaws; process refinements needed